by last | Nov 7, 2021 | 2021, Past Events
Philogen is presenting a ePoster on the results of the run-in part of the Phase II study with Fibromun plus Dacarbazine for patients with in third or later line advanced/metastatic soft tissue sarcoma. See here for more details.by last | Nov 6, 2021 | 2021, Past Events
Philogen announces its attendance at the Festival of Biologics Basel on November 10, 2021 Lisa Nadal, 3-year PhD student at Philogen, is giving a lecture entitled “A novel IL12-based immunocytokine targeting Fibroblast Activation Protein (FAP) for the treatment...by last | Nov 5, 2021 | Past Events
Stifel Conference provides an opportunity for investors to get a perspective of Philogen progresses and to meet CEO Dario Neri through a series of one-on-one meetings. Co-founder, CEO and CSO, Prof. Dario Neri is giving a 30 minutes presentation on November 16, 2021...by last | Nov 3, 2021 | 2021, Past Events
Dario Neri, co-founder, CEO and CSO, is giving a presentation focused on Tripokin, a novel fusion protein capable of an exceptionally selective uptake at the tumor site. The product contains two highly synergistic cytokine moieties (interleukin-2 and tumor necrosis...by last | Oct 20, 2021 | 2021, Past Events
Listen to Webcast